F
Frank Buttgereit
Researcher at Charité
Publications - 442
Citations - 23571
Frank Buttgereit is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Rheumatoid arthritis. The author has an hindex of 66, co-authored 392 publications receiving 19854 citations. Previous affiliations of Frank Buttgereit include Leibniz Association & Humboldt State University.
Papers
More filters
Journal ArticleDOI
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen,Robert Landewé,Ferdinand C. Breedveld,Maya H Buch,Maya H Buch,Gerd R Burmester,Maxime Dougados,Paul Emery,Paul Emery,Cécile Gaujoux-Viala,Laure Gossec,Jackie L Nam,Jackie L Nam,Sofia Ramiro,Kevin L. Winthrop,Maarten de Wit,Daniel Aletaha,Neil Betteridge,Johannes W. J. Bijlsma,Maarten Boers,Frank Buttgereit,Bernard Combe,Maurizio Cutolo,Nemanja Damjanov,Johanna M. W. Hazes,Marios Kouloumas,Tore K Kvien,Xavier Mariette,Karel Pavelka,Piet L. C. M. van Riel,Andrea Rubbert-Roth,Marieke Scholte-Voshaar,David Scott,T. Sokka-Isler,John B. Wong,Désirée van der Heijde +35 more
TL;DR: These recommendations intend informing rheumatologists, patients, national rheumology societies, hospital officials, social security agencies and regulators about EULAR's most recent consensus on the management of RA, aimed at attaining best outcomes with current therapies.
Journal ArticleDOI
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Bernhard Hellmich,Ana Filipa Águeda,Sara Monti,Frank Buttgereit,Hubert de Boysson,Elisabeth Brouwer,Rebecca Cassie,Maria C. Cid,Bhaskar Dasgupta,Christian Dejaco,Gulen Hatemi,Nicole Hollinger,Alfred Mahr,Susan P Mollan,Chetan Mukhtyar,Cristina Ponte,Carlo Salvarani,Rajappa Sivakumar,Xinping Tian,Gunnar Tomasson,Carl Turesson,Wofgang Schmidt,Peter M. Villiger,Richard A. Watts,Chris Young,Raashid Luqmani +25 more
TL;DR: The recommendations for the management of LVV have been updated to facilitate the translation of current scientific evidence and expert opinion into better management and improved outcome of patients in clinical practice.
Journal ArticleDOI
Genomic and nongenomic effects of glucocorticoids.
Cindy Stahn,Frank Buttgereit +1 more
TL;DR: Improved understanding of mechanisms of glucocorticoid action could enable the development of novel drugs with which to treat patients with inflammatory and autoimmune disease.
Journal ArticleDOI
Quantitating Protein Synthesis, Degradation, and Endogenous Antigen Processing
Michael F. Princiotta,Diana Finzi,Shu-Bing Qian,James P. Gibbs,Sebastian Schuchmann,Frank Buttgereit,Jack R. Bennink,Jonathan W. Yewdell +7 more
TL;DR: The macroEconomics of protein synthesis and degradation and the microeconomics of producing MHC class I associated peptides from viral translation products are quantitated and the efficiency of complex formation is similar in dendritic cells and macrophages, which play a critical role in activating T cells in vivo.
Journal ArticleDOI
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
J. A. P. Da Silva,J. W. G. Jacobs,John R. Kirwan,Maarten Boers,Kenneth G. Saag,Luís Inês,E J P de Koning,Frank Buttgereit,Maurizio Cutolo,H Capell,Rolf Rau,Johannes W. J. Bijlsma +11 more
TL;DR: Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo.